[Abstract] Objective: To investigate the effects on the nervous YANGXUEQINGNAOKELI patients with depression and serum after cerebral infarction. Methods: June 2016 - June 2019 after cerebral infarction depression included 100 patients in our hospital as research subjects, divided into two groups according to random number table, the control group on the basis of conventional therapy plus Paluoxiting treatment; observation group YANGXUEQINGNAOKELI treatment group based on the use, respectively, using Princeton Hamilton depression scale (HAMD) after treatment, Hamilton anxiety scale (HAMA), neurological deficit scores stroke scale (NIHSS ) scored two groups of patients before and after treatment were compared in patients with cortisol, noradrenaline (NE), Dopamine (DA) and 5-hydroxytryptamine (5-HT) levels. Results: After treatment, both groups NIHSS, HAMD, HAMA score, significantly lower cortisol levels than those before treatment, observation group was significantly lower than control group (P <0.05), two groups of 5-HT, DA and NE were significantly increased, and the observation group was significantly higher (P <0.05); groups rate of adverse reactions was no significant difference (P> 0.05). Conclusion: YANGXUEQINGNAOKELI joint Paluoxiting can improve neurological function in patients with depression after cerebral infarction, regulate a number of indicators in serum levels of 5-HT, etc., to improve the symptoms of anxiety and depression in patients with significant effect without increasing side effects.
正在翻译中..